Back

Real world evaluation of lipoprotein (a) testing and impact on LDL-C management in atherosclerotic cardiovascular disease patients: findings from the CVMOBIUS2 registry

30 August 2026 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Lipids and cardiovascular risk (1) Lipids ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Nishant P Shah

Duke University Health System, Cary (United States of America)

6 More presentations in this session

Presentation thumbnail
Excess atherosclerotic cardiovascular burden associated with elevated lipoprotein(a) across age, sex, and cardiometabolic risk factors: insights from 16-year follow-up of the HUNT Study
Mr Y. Khalil (Trondheim, NO)
Abstract Slides Video
Presentation thumbnail
Intra-individual lipoprotein(a) variability and risk reclassification in patients with cardiovascular disease
Miss C. Zhang (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Higher liver fat content is associated with lower lipoprotein(a) concentrations in men and postmenopausal women
Doctor M. Markus (Greifswald, DE)
Abstract Slides Video
Presentation thumbnail
Determinants of lipoprotein(a) test utilization in Ontario following public reimbursement: a population-based analysis
Doctor L. Godoy (Ottawa, CA)
Abstract Slides Video
Presentation thumbnail
Lipoprotein(a) associates with circulating annexin a1-positive extracellular vesicles linked to arterial calcification
Doctor P. Haider (Vienna, AT)
Abstract Slides Video

Access the full session

Session thumbnail
Lipids and cardiovascular risk (1)

The Event

Event poster

ESC Congress 2026

30 August 2026 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Trends and disparities in lipoprotein(a) testing from 2016-2025: a large-scale interrupted time series analysis
29 August 2026
thumbnail
Congress Presentation
Impact of elevated lipoprotein(a) on LDL-C lowering efficacy in ACS patients undergoing triple lipid-lowering therapy: insights from LAI-REACT-LP(a) sub-study
31 August 2025
thumbnail
Congress Presentation
Lipid management in patients with coronary artery disease at risk of a first major atherosclerotic cardiovascular event: findings from the VESALIUS-REAL global study
29 August 2026
thumbnail
Congress Presentation
Temporal trends in lipid-lowering therapy utilization among ASCVD patients: a large-scale database analysis
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources